Articles

marketwatch.com
—
Israeli drug maker Teva Pharmaceutical Industries Ltd. is in talks to combine with Allergan PLC's big generic-drug business, in a move that would further consolidation in the health-care industry and likely mean the end of Teva's pursuit of another acquisition.

wsj.com
—
Israeli drug maker Teva Pharmaceutical Industries Ltd. is in talks to combine with Allergan PLC's big generic-drug business, according to people familiar with the matter, in a move that would represent a continuation of a boom in healthcare dealmaking and likely mean the end of Teva's pursuit of another acquisition.

wsj.com
—
Grocer has lined up buyers for 120 stores valued at about $600 million A&P is planning to file for bankruptcy, the second time in less than five years the grocery chain has sought creditor protection amid stiff competition.

wsj.com
—
Fertilizer maker CF Industries Holdings Inc. is in advanced talks for a merger deal with Dutch counterpart OCI NV, as chemical companies join the global takeover wave. CF, of Deerfield, Ill., and OCI are in discussions about a tie-up that could be reached as early as this month, according to people familiar with the matter.

wsj.com
—
For years after the financial crisis, fear kept corporate chiefs from striking merger-and-acquisition deals. Now it is prompting them to act. Companies are merging at a pace unseen in nearly a decade. Halfway through the year, about $2.15 trillion in M&A deals or offers have been announced globally, according to Dealogic.

marketwatch.com
—
Valeant Pharmaceuticals International Inc. has made a preliminary approach to buy animal-health giant Zoetis Inc., people familiar with the matter said, in a move that could presage a big deal in yet another corner of the health-care industry. Zoetis which was spun off from Pfizer Inc.

wsj.com
—
Valeant Pharmaceuticals International Inc. has made a preliminary approach to buy animal-health giant Zoetis Inc., people familiar with the matter said, in a move that could presage a big deal in yet another corner of the health-care industry. Zoetis, which was spun off from Pfizer Inc.

wsj.com
—
Shares of Williams Cos., a large natural-gas pipeline operator in the U.S., surged on Monday after it rejected a nearly $50 billion buyout offer. The gain puts pressure on Williams to find a richer deal or prove it can deliver better results as a stand-alone company, Wall Street analysts said.

wsj.com
—
Pipeline company retains Barclays and Lazard to pursue alternatives Natural-gas pipeline giant Williams Cos. has rejected an unsolicited buyout offer worth $48 billion but is open to other offers, the company said Sunday. Williams announced Sunday evening that it was approached about an all-stock deal valued at $64 a share.

marketwatch.com
—
Intensifying a five-way merger frenzy, Anthem Inc. went public Saturday with a sweetened $47.5 billion takeover offer for Cigna Corp. and Aetna Inc. in recent days made a takeover proposal for Humana Inc. Anthem in a statement said it has offered $184 a share for Cigna That equates to about $47.5 billion for all the company's stock that was recently outstanding.